Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Oragenics, Inc. on March 27, 2026. The filing reports a corporate governance event regarding the scheduling of the company's 2025 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report on a specific event and does not contain financial statements or performance metrics.
Material Changes
The Board of Directors determined to change the date of the 2025 Annual Meeting of Shareholders to June 29, 2026. This date is more than 30 days from the anniversary of the 2024 Annual Meeting, triggering a requirement under Rule 14a-5(f) of the Exchange Act to notify shareholders.
Guidance, Outlook, and Risks
Due to the change in the annual meeting date, a new deadline for shareholder proposals intended for inclusion in the 2025 proxy statement has been established. Proposals must be received by May 1, 2026. The filing does not contain management commentary on financial outlook, risks, or contingencies.
Key Facts for Investors to Verify
- The 2025 Annual Meeting of Shareholders is scheduled for June 29, 2026.
- The deadline for submitting shareholder proposals for the 2025 proxy statement is May 1, 2026.
- Proposals must be delivered to the Corporate Secretary at 9015 Town Center Parkway, Suite 143, Lakewood Ranch, Florida 34202.
- The record date, time, and location for the meeting will be detailed in the upcoming proxy statement.